4th Quarter - Report

AVENUE SOLUTIONS for GENENTECH USA, INC.

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issues related to Inflation Reduction Act of 2022 (PL 117-169) implementation; Issues related to healthcare access, quality and costs; Issues related to Medicare and Medicaid coverage and reimbursement; Medicare reimbursement for biosimilars

LobbyistCovered position, as disclosed
ELIZABETH MACDONALD BARNETT —
TRACY SPICER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Issues related to Pandemic and All Hazards Preparedness Act (PAHPA) reauthorization; Issues related to the expiration/extension of Priority Review Vouchers (PRVs) for rare disease; Issues related to 340b drug pricing program; H.R. 10545, American Relief Act, 2025

LobbyistCovered position, as disclosed
ELIZABETH MACDONALD BARNETT —
TRACY SPICER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 10545 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.